Clinical trials recruiting in Ha’erbin, China

Phase breakdown

Conditions recruiting in Ha’erbin, China

Recruiting trials in Ha’erbin, China

• A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
  NCT06111274 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study of Metformin to Improve Cardiac Function After LVAD Implantation
  NCT07666698 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
  NCT06079983 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Real-world Study Optimizing Nucleotide-analogues
  NCT05937178 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
  NCT06712355 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
  NCT04930432 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Ha’erbin, China?

6 recruiting trials have at least one study site in Ha’erbin, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.